Untapped Markets Fuel Strong Sales in Global Protein Expression Market

WELLESLEY, Mass., February 26, 2019 (Newswire.com) - A significant surge in demand for protein expression systems, rising incidence of chronic diseases, increasing expenditures on research and development and untapped markets in developing economies are contributors to the growth of the global protein expression market, according to a new report by BCC Research.

Valued at $1.8 billion in 2017, the worldwide protein expression market was expected to reach nearly $3.1 billion in 2022 at a compound annual growth rate (CAGR) of 11.3% during the forecast period, according to the report “Protein Expression: Global Markets.”

Major players in the industry include Thermo Fisher Scientific Inc., Merck KGaA, Promega Corp., Agilent Technologies Inc., GenScript, Takara Holdings Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Lonza Group AG, New England BioLabs Inc., and others.

Research Highlights:

• By type, yeast cell expression systems were poised to undergo the fastest growth, with a CAGR of 12.8%. Prokaryotic expression systems were projected to top $1 billion in 2022, making it the largest segment in terms of value.
• By-products and services, the reagents segment has dominated the global market and was anticipated to register a CAGR of 10.9% in 2022, with revenue expected to reach $1.7 billion.
• By region, Asia-Pacific was expected to have the highest CAGR (12.0%), with revenues to reach $687 million by 2022.

“Various protein expression systems are available that have proven beneficial for therapeutic uses, such as treatment of patients with chronic and infectious diseases. For instance, protein expression is helping to identify treatment options for cancer,” said Sangeeta Rai, the report’s author. “It is critical to have access to a variety of tools to ensure successful expression of the required target protein.”

Market Restraint: Stringent Regulatory Actions

For protein expression, stringent controls are enforced. Expression frameworks must conform to the essential rules of the administrative bodies; otherwise, the products can be recalled or halted from moving forward. Accordingly, organizations associated with the improvement of different expression systems should be cautious regarding the rules.

Editors/reporters requesting analyst interviews should contact Eric Surber at [email protected].

Source: BCC Research